ArticleMolecular cancer therapeutics2021

Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors.

Michael S Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.